These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9296716)
1. [Inhibition of generalization of wound infection in immunized rats]. Pal'tsyn AA; Grishina IA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Popova EP Biull Eksp Biol Med; 1994 May; 117(5):545-6. PubMed ID: 9296716 [No Abstract] [Full Text] [Related]
2. [The cause of benign and malignant courses of infection due to different strains of Pseudomonas aeruginosa]. Pal'tsyn AA; Tepliakov VG; Chervonskaia NV; Grishina IA; Popova EA Biull Eksp Biol Med; 1993 Oct; 116(10):421-4. PubMed ID: 8117973 [TBL] [Abstract][Full Text] [Related]
3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers]. Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666 [TBL] [Abstract][Full Text] [Related]
4. [Sensitization to Pseudomonas aeruginosa in thermal burn patients]. Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796 [No Abstract] [Full Text] [Related]
5. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [TBL] [Abstract][Full Text] [Related]
6. [Bacteriopyncnosis--morphological expression of bacterial death in an animal]. Pal'tsyn AA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Grishina IA; Popova EP Biull Eksp Biol Med; 1995 Jun; 119(6):665-8. PubMed ID: 8589403 [No Abstract] [Full Text] [Related]
7. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242 [TBL] [Abstract][Full Text] [Related]
9. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases]. Zarubina EK; Svetukhin AM; Edvabnaia LS Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579 [No Abstract] [Full Text] [Related]
10. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns. Jones RJ; Lowbury EJ Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411 [TBL] [Abstract][Full Text] [Related]
11. [Infections in minks caused by Pseudomonas aeruginosa. Infection and vaccination trials]. Karlsson KA; Kull KE; Svanholm R Nord Vet Med; 1971; 23(7):345-51. PubMed ID: 5004400 [No Abstract] [Full Text] [Related]
12. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice. Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793 [TBL] [Abstract][Full Text] [Related]
13. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
14. [Immunogenic properties of the liposomal form of Pseudomonas aeruginosa anatoxin]. Minukhin VV; Brodinova NS; Tsyganenko AIa; Ivanova NN; Vasil'chenko VN; Sennikov GA Vestn Akad Med Nauk SSSR; 1990; (8):44-7. PubMed ID: 2125778 [TBL] [Abstract][Full Text] [Related]
15. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections. Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760 [TBL] [Abstract][Full Text] [Related]
16. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients. Roe EA; Jones RJ Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970 [TBL] [Abstract][Full Text] [Related]
17. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland]. Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869 [No Abstract] [Full Text] [Related]
18. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients]. Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103 [No Abstract] [Full Text] [Related]
19. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia. Sokol PA; Kooi C; Hodges RS; Cachia P; Woods DE J Infect Dis; 2000 May; 181(5):1682-92. PubMed ID: 10823769 [TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of sepsis in burns. Lowbury EJ Proc R Soc Med; 1972 Jan; 65(1):25-7. PubMed ID: 4335587 [No Abstract] [Full Text] [Related] [Next] [New Search]